Canadian competion during a US generic drug's 180-day exclusivity period

被引：0

作者：

Richard, K. M. ^{[1
]}

Shepherd, M. D. ^{[1
]}

机构：

[1] Univ Texas Austin, Austin, TX USA

来源：

VALUE IN HEALTH | 2007年 / 10卷 / 06期

关键词：

D O I：

10.1016/S1098-3015(10)65282-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A361 / A362

页数：2

共 50 条

[1] The Simple Math of Royalties and Drug Competition During the 180-Day Generic Exclusivity Period
Drake, Keith M.
McGuire, Thomas G.
JOURNAL OF COMPETITION LAW & ECONOMICS, 2024, 20 (1-2) : 50 - 59
[2] The Law of 180-Day Exclusivity
Lietzan, Erika
Post, Julia
FOOD AND DRUG LAW JOURNAL, 2016, 71 (03) : 327 - 400
[3] Issues in the interpretation of 180-day exclusivity
Lietzan, Erika
Korn, David E.
FOOD AND DRUG LAW JOURNAL, 2007, 62 (01) : 49 - 75
[4] A New History and Discussion of 180-Day Exclusivity
Korn, David E.
Lietzan, Erika
Scott, Shaw W.
FOOD AND DRUG LAW JOURNAL, 2009, 64 (02) : 335 - 390
[5] Economic impact of Prozac® patent expiration and the 180-day generic fluoxetine exclusivity in a publicly-financed prescription program
Punjabi, SS
Johnsrud, MT
Conner, C
VALUE IN HEALTH, 2003, 6 (03) : 192 - 193
[6] US courts disagree on generic drug exclusivity
Chahine, K
NATURE BIOTECHNOLOGY, 1998, 16 (02) : 132 - 132
[7] US courts disagree on generic drug exclusivity
Ken Chahine
Nature Biotechnology, 1998, 16 : 132 - 132
[8] 2004 update - 180-day exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act
Lietzan, EK
FOOD AND DRUG LAW JOURNAL, 2004, 59 (04) : 459 - 463
[9] A brief history of 180-day exclusivity under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act
Lietzan, EK
FOOD AND DRUG LAW JOURNAL, 2004, 59 (02) : 287 - +
[10] The 180-day lock-up period and insiders' equity selling
Ayayi A.
Journal of Economics and Finance, 2005, 29 (1) : 32 - 45

← 1 2 3 4 5 →